LS

Lakshmi Satchidanandam Singaraju

Active Director Director DIN 00006815
DIN 00006815 First appointment Apr 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmi Satchidanandam Singaraju

Data last updated:

Lakshmi Satchidanandam Singaraju is a Director at Srinivas Therapeutics Private Limited (since 2006). The company operates in Chemicals.

DIN 00006815
Primary Designation Director
Industry Chemicals
First Appointment 12 Apr 2006
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Apr 20062006Active

Board colleagues of Lakshmi Satchidanandam Singaraju

Directorship timeline

Open interactive timeline →
Srinivas Therapeutics Private Limited
Premium access

Shareholding and investment profile for Lakshmi Satchidanandam Singaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmi Satchidanandam Singaraju

Lakshmi Satchidanandam Singaraju currently holds 1 directorship: Srinivas Therapeutics Private Limited (Director, since 12 Apr 2006).

Lakshmi Satchidanandam Singaraju was first appointed on 12 Apr 2006 as Director at Srinivas Therapeutics Private Limited.

The current boards of Lakshmi Satchidanandam Singaraju's companies include Prabhakar Appalakutti (Srinivas Therapeutics Private Limited), Thimmavajala Kumar Prabhu (Srinivas Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available